Given the high volume of seasonal work facing proxy advisors, it may be tempting to base research of some policies off of a “benchmark”

Dillard’s Texas reincorporation shows that even with shareholder-unfriendly governance, strong returns can outweigh “best practice” concerns.

Class action “killing fields” ahead? Pfizer & Moderna face mounting lawsuits over COVID vaccine risks—investors should take notice.

Shareholders should hold Under Armour’s long-standing directors accountable for years of underperformance—vote AGAINST six incumbents.

Rising yields fuel concern, but history and policy suggest U.S. Treasuries remain secure, with Fed and fiscal moves ensuring timely payment.

Geopolitical shifts show nuclear deterrence weakening, Russia vulnerable, and China eyeing opportunities—reshaping global risk.

AI-driven productivity gains may justify lofty valuations, but risks of uneven growth and tech hype cycles suggest caution in today’s market outlook.

Egan-Jones recommends that shareholders vote AGAINST all proposals in the Lifeway Foods consent solicitation.

Enron’s collapse exposed the cost of conflicted advice. Independence in auditing—and proxy guidance—still matters.

Egan-Jones recommends voting FOR all six of Ortelius’s nominees at Brookdale (BKD), rejecting a split slate in favor of strategic change.

Dynavax faces a pivotal choice: return profits to shareholders or invest in new products—an empire in the making or a focus on proven success?

As featured in the HLS Forum on Corporate Governance: Say-on-pay proposals have become a hot-button-issue for proxy advisors.

Over the past five years, Harley-Davidson (NYSE:HOG) has yielded -11% returns for investors.

Not all top-performing firms follow governance “best practices.” It’s time investors rethink rigid rules in favor of what truly drives shareholder wealth.

Stock buybacks have recently garnered attention in politics and corporate governance.